A HORRIFIED mum was forced to suck out 40 bee stings from her toddler's skin after he was attacked by a huge swarm - ...

Dupilumab (Dupixent), a fully human monoclonal antibody that targets the interleukin (IL)-4 and IL-13 pathways, is currently ...

Incyte’s pipeline updates on Monday bring into question the value of its $750 million Escient acquisition in April 2024—and ...

While some skin lesions may look like scars, others may have boils, hives and blisters. Some lesions may even result in some rashes or freckles. Any areas of skin that are abnormal and do not look ...

Image Source: Zacks Investment Research CSU is an inflammatory skin condition, primarily occurring due to type 2 inflammation ...

Jasper Therapeutics faces financial challenges but strong buy ratings. Read why JSPR stock is poised for growth amid risks ...

Honey bees symmetrically organize nest contents, benefiting brood development and temperature control, consistent across species. Symmetry is everywhere and serves a myriad of purposes. Humans find ...

We recently published a list of 10 Best Multibagger Stocks To Buy Heading into 2025. In this article, we are going to take a ...

The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.

The FDA has provided a date of April 18, 2025, to review the application for Dupixent to treat patients with chronic ...

Regeneron and Sanofi's Dupixent sBLA for treating chronic spontaneous urticaria in patients 12+ gets FDA review, with a ...

The FDA last year turned away the companies' application and asked for additional efficacy data. Regeneron and Sanofi said the resubmission adds results from an additional Phase 3 study of Dupixent in ...